Rotigotine API, also known as rotigotine hydrochloride, is a non-ergot dopamine agonist used to treat Parkinson's disease (PD) and moderate-to-severe primary restless legs syndrome (RLS). It is a transdermal patch that provides a slow and continuous release of rotigotine into the bloodstream over a 24-hour period. Mechanism of Action Rotigotine API works by mimicking the actions of...